{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:34:37Z","timestamp":1792636477066,"version":"4.5.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private Universit\u00e4t Witten\/Herdecke gGmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is one of the most common degenerative brain disorders caused by the loss of dopaminergic neurons in the substantia nigra (SN). Lewy bodies and -synuclein accumulation in the SN are hallmarks of the neuropathology of PD. Due to lifestyle changes and prolonged L-dopa administration, patients with PD frequently have vitamin deficiencies, especially folate, vitamin B6, and vitamin B12. These disorders augment circulating levels of Homocysteine with the development of hyperhomocysteinemia, which may contribute to the pathogenesis of PD. Therefore, this review aimed to ascertain if hyperhomocysteinemia may play a part in oxidative and inflammatory signaling pathways that contribute to PD development. Hyperhomocysteinemia is implicated in the pathogenesis of neurodegenerative disorders, including PD. Hyperhomocysteinemia triggers the development and progression of PD by different mechanisms, including oxidative stress, mitochondrial dysfunction, apoptosis, and endothelial dysfunction. Particularly, the progression of PD is linked with high inflammatory changes and systemic inflammatory disorders. Hyperhomocysteinemia induces immune activation and oxidative stress. In turn, activated immune response promotes the development and progression of hyperhomocysteinemia. Therefore, hyperhomocysteinemia-induced immunoinflammatory disorders and abnormal immune response may aggravate abnormal immunoinflammatory in PD, leading to more progression of PD severity. Also, inflammatory signaling pathways like nuclear factor kappa B (NF-\u03baB) and nod-like receptor pyrin 3 (NLRP3) inflammasome and other signaling pathways are intricate in the pathogenesis of PD. In conclusion, hyperhomocysteinemia is involved in the development and progression of PD neuropathology either directly via induction degeneration of dopaminergic neurons or indirectly via activation of inflammatory signaling pathways.<\/jats:p>","DOI":"10.1007\/s10571-023-01350-8","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T05:02:11Z","timestamp":1681880531000},"page":"2743-2759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Parkinson\u2019s Disease Risk and Hyperhomocysteinemia: The Possible Link"],"prefix":"10.1007","volume":"43","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-4587","authenticated-orcid":false,"given":"Yaser Hosny Ali","family":"Elewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2108-0604","authenticated-orcid":false,"given":"Mahmoud Hosny","family":"Zahran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-425X","authenticated-orcid":false,"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","first-page":"7934442","DOI":"10.1155\/2022\/7934442","volume":"2022","author":"AT Aborode","year":"2022","unstructured":"Aborode AT, Pustake M, Awuah WA, Alwerdani M, Shah P, Yarlagadda R, Ahmad S, Silva Correia IF, Chandra A, Nansubuga EP, Abdul-Rahman T, Mehta A, Ali O, Amaka SO, Zu\u00f1iga YMH, Shkodina AD, Inya OC, Shen B, Alexiou A (2022) Targeting oxidative stress mechanisms to treat alzheimer\u2019s and parkinson\u2019s disease: a critical review. Oxid Med Cell Longev 2022:7934442. https:\/\/doi.org\/10.1155\/2022\/7934442","journal-title":"Oxid Med Cell Longev"},{"key":"1350_CR2","doi-asserted-by":"publisher","first-page":"117957352096223","DOI":"10.1177\/1179573520962230","volume":"12","author":"F Al Mutairi","year":"2020","unstructured":"Al Mutairi F (2020) Hyperhomocysteinemia: clinical Insights. J Cent Nerv Syst Dis 12:1179573520962230. https:\/\/doi.org\/10.1177\/1179573520962230","journal-title":"J Cent Nerv Syst Dis"},{"issue":"2","key":"1350_CR3","first-page":"81","volume":"14","author":"AI Al-Gareeb","year":"2016","unstructured":"Al-Gareeb AI, Abd Al-Amieer WS, Alkuraishy HM, Al-Mayahi TJ (2016) Effect of body weight on serum homocysteine level in patients with polycystic ovarian syndrome: a case control study. Int Reprod BioMed 14(2):81","journal-title":"Int Reprod BioMed"},{"issue":"1","key":"1350_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/japtr.JAPTR_330_18","volume":"10","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2019) Effects of rosuvastatin on metabolic profile: Versatility of dose-dependent effect. J Adv Pharm Technol Res 10(1):33","journal-title":"J Adv Pharm Technol Res"},{"issue":"1","key":"1350_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/2230-8210.172240","volume":"20","author":"HM Al-Kuraishy","year":"2016","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Awad MS, Alrifai SB (2016) Assessment of serum prolactin levels in acute myocardial infarction: the role of pharmacotherapy. Indian J Endocrinol Metabol 20(1):72","journal-title":"Indian J Endocrinol Metabol"},{"issue":"2","key":"1350_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/bc.bc_42_19","volume":"6","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI (2020) Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review. Brain Circulation 6(2):70","journal-title":"Brain Circulation"},{"issue":"5","key":"1350_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/bbrj.bbrj_109_20","volume":"4","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Hussien NR, Al-Naimi MS, Al-Buhadily AK, Al-Gareeb AI, Lungnier C (2020) Is ivermectin\u2013azithromycin combination the next step for COVID-19? Biomed Biotechnol Res J 4(5):101","journal-title":"Biomed Biotechnol Res J"},{"issue":"11","key":"1350_CR8","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE (2021) The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem 476(11):4161\u20134166. https:\/\/doi.org\/10.1007\/s11010-021-04232-z","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"1350_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10753-022-01648-7","volume":"45","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Aljowaie RM, Almutairi SM, Alexiou A, Batiha GE (2022) The prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19. Inflammation 45(4):1651\u20131667","journal-title":"Inflammation"},{"key":"1350_CR10","first-page":"1","volume":"21","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, Khamjan NA, Saad HM, Batiha GE, De Waard M (2022) A potential link between visceral obesity and risk of alzheimer\u2019s disease. Neurochem Res 21:1\u201322","journal-title":"Neurochem Res"},{"key":"1350_CR11","first-page":"1","volume":"23","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE (2022) Benzodiazepines in Alzheimer\u2019s disease: beneficial or detrimental effects. Inflammopharmacology 23:1","journal-title":"Inflammopharmacology"},{"key":"1350_CR12","first-page":"1","volume":"18","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Batiha GE, Al-Gareeb AI, Al-Harcan NA, Welson NN (2023) Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon. Mol Cell Biochem 18:1\u20139","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"1350_CR13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/brainsci12101290","volume":"12","author":"N Alsubaie","year":"2022","unstructured":"Alsubaie N, Al-Kuraishy HM, Al-Gareeb AI, Alharbi B, De Waard M, Sabatier JM, Saad HM, Batiha GE (2022) Statins use in alzheimer disease: bane or boon from frantic search and narrative review. Brain Sci 12(10):1290","journal-title":"Brain Sci"},{"key":"1350_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbr.2013.09.017","volume":"256","author":"L An","year":"2013","unstructured":"An L, Zhang T (2013) Spatial cognition and sexually dimorphic synaptic plasticity balance impairment in rats with chronic prenatal ethanol exposure. Behav Brain Res 256:564\u2013574. https:\/\/doi.org\/10.1016\/j.bbr.2013.09.017","journal-title":"Behav Brain Res"},{"issue":"6","key":"1350_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"9","key":"1350_CR16","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/diagnostics12092051","volume":"12","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier JM, Saad HM, Batiha GE (2022) The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? Diagnostics 12(9):2051","journal-title":"Diagnostics"},{"key":"1350_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2021.1878539","author":"M Bagherieh","year":"2021","unstructured":"Bagherieh M, Kheirollahi A, Zamani-Garmsiri F, Emamgholipour S, Meshkani R (2021) Folic acid ameliorates palmitate-induced inflammation through decreasing Homocysteine and inhibiting NF-\u03baB pathway in HepG2 cells. Arch Physiol Biochem. https:\/\/doi.org\/10.1080\/13813455.2021.1878539","journal-title":"Arch Physiol Biochem"},{"key":"1350_CR18","doi-asserted-by":"publisher","first-page":"3124295","DOI":"10.1155\/2019\/3124295","volume":"2019","author":"MC Bakeberg","year":"2019","unstructured":"Bakeberg MC, Jefferson A, Riley M, Byrnes M, Ghosh S, Mastaglia FL, Horne MK, McGregor S, Stell R, Kenna J, Walters S, Hince D, Anderton RS (2019) Elevated serum homocysteine levels have differential gender-specific associations with motor and cognitive states in parkinson\u2019s disease. Parkinsons Dis 2019:3124295. https:\/\/doi.org\/10.1155\/2019\/3124295","journal-title":"Parkinsons Dis"},{"key":"1350_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","volume":"173","author":"B Balint","year":"2020","unstructured":"Balint B, Jepchumba VK, Gu\u00e9ant JL, Gu\u00e9ant-Rodriguez RM (2020) Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall. Biochimie 173:100\u2013106. https:\/\/doi.org\/10.1016\/j.biochi.2020.02.012","journal-title":"Biochimie"},{"key":"1350_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5604\/17322693.1102340","volume":"68","author":"A Baszczuk","year":"2014","unstructured":"Baszczuk A, Kopczy\u0144ski Z (2014) hyperhomocysteinemia in patients with cardiovascular disease. Postepy Hig Med Dosw (online) 68:579\u2013589. https:\/\/doi.org\/10.5604\/17322693.1102340","journal-title":"Postepy Hig Med Dosw (online)"},{"key":"1350_CR21","first-page":"1","volume":"29","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E (2022) SIRT1 pathway in Parkinson\u2019s disease: a faraway snapshot but so close. Inflammopharmacology 29:1\u201320","journal-title":"Inflammopharmacology"},{"key":"1350_CR22","doi-asserted-by":"publisher","first-page":"e01407","DOI":"10.1016\/j.sciaf.2022.e01407","volume":"22","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Gareeb AI, Rotimi D, Adeyemi OS, Al-Kuraishy HM (2022) Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer. Scientific African 22:e01407","journal-title":"Scientific African"},{"key":"1350_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuint.2016.10.001","volume":"101","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Borah A (2016) Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson\u2019s disease. Neurochem Int 101:48\u201355. https:\/\/doi.org\/10.1016\/j.neuint.2016.10.001","journal-title":"Neurochem Int"},{"key":"1350_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neulet.2016.06.011","volume":"628","author":"N Bhattacharjee","year":"2016","unstructured":"Bhattacharjee N, Mazumder MK, Paul R, Choudhury A, Choudhury S, Borah A (2016) L-DOPA treatment in MPTP-mouse model of Parkinson\u2019s disease potentiates homocysteine accumulation in substantia nigra. Neurosci Lett 628:225\u2013229. https:\/\/doi.org\/10.1016\/j.neulet.2016.06.011","journal-title":"Neurosci Lett"},{"key":"1350_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat C, Nalls M, Singleton A (2019) The genetic architecture of Parkinson\u2019s disease. The Lancet Neurology. https:\/\/doi.org\/10.1016\/S1474-4422(19)30287-X","journal-title":"The Lancet Neurology"},{"issue":"5","key":"1350_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10072-019-03738-1","volume":"40","author":"A Bougea","year":"2019","unstructured":"Bougea A, Stefanis L, Paraskevas GP, Emmanouilidou E, Vekrelis K, Kapaki E (2019) Plasma alpha-synuclein levels in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. Neurol Sci 40(5):929\u2013938. https:\/\/doi.org\/10.1007\/s10072-019-03738-1","journal-title":"Neurol Sci"},{"key":"1350_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010314","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Al-Rawas AM, Al-Maqbali M, Al-Saleh M, Enriquez MB, Al-Siyabi S, Al-Hashmi K, Al-Lawati I, Bulthuis MLC, Mulder DJ, Gordijn SJ, van Goor H, Saleh J (2020) Systemic oxidative stress is increased in postmenopausal women and independently associates with homocysteine levels. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21010314","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1350_CR28","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.4049\/jimmunol.1801416","volume":"202","author":"N Boxberger","year":"2019","unstructured":"Boxberger N, Hecker M, Zettl UK (2019) Dysregulation of inflammasome priming and activation by micrornas in human immune-mediated diseases. J Immunol 202(8):2177\u20132187. https:\/\/doi.org\/10.4049\/jimmunol.1801416","journal-title":"J Immunol"},{"issue":"1","key":"1350_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.neurobiolaging.2014.07.043","volume":"36","author":"C Buddhala","year":"2015","unstructured":"Buddhala C, Campbell MC, Perlmutter JS, Kotzbauer PT (2015) Correlation between decreased CSF \u03b1-synuclein and A\u03b21-42 in Parkinson disease. Neurobiol Aging 36(1):476\u2013484. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.043","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1350_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bcp.12357","volume":"78","author":"S Cahill-Smith","year":"2014","unstructured":"Cahill-Smith S, Li JM (2014) Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2. Br J Clin Pharmacol 78(3):441\u2013453. https:\/\/doi.org\/10.1111\/bcp.12357","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"1350_CR31","doi-asserted-by":"publisher","first-page":"e0236820","DOI":"10.1371\/journal.pone.0236820","volume":"15","author":"AM Carapellotti","year":"2020","unstructured":"Carapellotti AM, Stevenson R, Doumas M (2020) The efficacy of dance for improving motor impairments, non-motor symptoms and quality of life in Parkinson\u2019s disease: a systematic review and meta-analysis. PLoS One 15(8):e0236820. https:\/\/doi.org\/10.1371\/journal.pone.0236820","journal-title":"PLoS One"},{"issue":"1","key":"1350_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.075","volume":"332","author":"F Chen","year":"2005","unstructured":"Chen F (2005) Is NF-kappaB a culprit in type 2 diabetes? Biochem Biophys Res Commun 332(1):1\u20133. https:\/\/doi.org\/10.1016\/j.bbrc.2005.03.075","journal-title":"Biochem Biophys Res Commun"},{"key":"1350_CR33","doi-asserted-by":"publisher","first-page":"7371403","DOI":"10.1155\/2017\/7371403","volume":"2017","author":"MH Chen","year":"2017","unstructured":"Chen MH, Chen PC, Lu CH, Chen HL, Chao YP, Li SH, Chen YW, Lin WC (2017) Plasma DNA mediate autonomic dysfunctions and white matter injuries in patients with parkinson\u2019s disease. Oxid Med Cell Longev 2017:7371403. https:\/\/doi.org\/10.1155\/2017\/7371403","journal-title":"Oxid Med Cell Longev"},{"key":"1350_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2019.06.024","volume":"141","author":"B Chen","year":"2019","unstructured":"Chen B, Wen X, Jiang H, Wang J, Song N, Xie J (2019) Interactions between iron and \u03b1-synuclein pathology in Parkinson\u2019s disease. Free Radic Biol Med 141:253\u2013260. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.06.024","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"1350_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/mds.27301","volume":"33","author":"CW Christine","year":"2018","unstructured":"Christine CW, Auinger P, Joslin A, Yelpaala Y, Green R (2018) Vitamin B12 and homocysteine levels predict different outcomes in early parkinson\u2019s disease. Mov Disord 33(5):762\u2013770. https:\/\/doi.org\/10.1002\/mds.27301","journal-title":"Mov Disord"},{"issue":"7","key":"1350_CR36","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/jth.13340","volume":"14","author":"YC Chung","year":"2016","unstructured":"Chung YC, Kruyer A, Yao Y, Feierman E, Richards A, Strickland S, Norris EH (2016) Hyperhomocysteinemia exacerbates Alzheimer\u2019s disease pathology by way of the \u03b2-amyloid fibrinogen interaction. J Thromb Haemost 14(7):1442\u20131452. https:\/\/doi.org\/10.1111\/jth.13340","journal-title":"J Thromb Haemost"},{"key":"1350_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040612","author":"FC Church","year":"2021","unstructured":"Church FC (2021) Treatment options for motor and non-motor symptoms of parkinson\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom11040612","journal-title":"Biomolecules"},{"issue":"1","key":"1350_CR38","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M (2013) Triggering of inflammasome by aggregated \u03b1-synuclein, an inflammatory response in synucleinopathies. PLoS One 8(1):e55375. https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS One"},{"key":"1350_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11010037","author":"M Cordaro","year":"2021","unstructured":"Cordaro M, Siracusa R, Fusco R, Cuzzocrea S, Di Paola R, Impellizzeri D (2021) Involvements of hyperhomocysteinemia in neurological disorders. Metabolites. https:\/\/doi.org\/10.3390\/metabo11010037","journal-title":"Metabolites"},{"issue":"8","key":"1350_CR40","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s11064-012-0769-2","volume":"37","author":"AA da Cunha","year":"2012","unstructured":"da Cunha AA, Ferreira AG, Loureiro SO, da Cunha MJ, Schmitz F, Netto CA, Wyse AT (2012) Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 37(8):1660\u20131669. https:\/\/doi.org\/10.1007\/s11064-012-0769-2","journal-title":"Neurochem Res"},{"key":"1350_CR41","doi-asserted-by":"publisher","first-page":"6652231","DOI":"10.1155\/2021\/6652231","volume":"2021","author":"C Dai","year":"2021","unstructured":"Dai C, Fei Y, Li J, Shi Y, Yang X (2021) A novel review of homocysteine and pregnancy complications. Biomed Res Int 2021:6652231. https:\/\/doi.org\/10.1155\/2021\/6652231","journal-title":"Biomed Res Int"},{"issue":"2","key":"1350_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","volume":"67","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM (2006) Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 67(2):315\u2013318. https:\/\/doi.org\/10.1212\/01.wnl.0000225050.57553.6d","journal-title":"Neurology"},{"key":"1350_CR43","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6895.1000107","author":"GH Doherty","year":"2013","unstructured":"Doherty GH (2013) Homocysteine and parkinsons disease: a complex relationship. J Neurol Dis. https:\/\/doi.org\/10.4172\/2329-6895.1000107","journal-title":"J Neurol Dis"},{"key":"1350_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15242","author":"M Dolatshahi","year":"2021","unstructured":"Dolatshahi M, Ranjbar Hameghavandi MH, Sabahi M, Rostamkhani S (2021) Nuclear factor-kappa B (NF-\u03baB) in pathophysiology of Parkinson disease: diverse patterns and mechanisms contributing to neurodegeneration. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.15242","journal-title":"Eur J Neurosci"},{"key":"1350_CR45","doi-asserted-by":"publisher","first-page":"119386","DOI":"10.1016\/j.lfs.2021.119386","volume":"277","author":"TM Dos Santos","year":"2021","unstructured":"Dos Santos TM, Ramires J\u00fanior OV, Alves VS, Coutinho-Silva R, Savio LEB, Wyse ATS (2021) Hyperhomocysteinemia alters cytokine gene expression, cytochrome c oxidase activity and oxidative stress in striatum and cerebellum of rodents. Life Sci 277:119386. https:\/\/doi.org\/10.1016\/j.lfs.2021.119386","journal-title":"Life Sci"},{"issue":"1","key":"1350_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. J Neurochem 80(1):101\u2013110. https:\/\/doi.org\/10.1046\/j.0022-3042.2001.00676.x","journal-title":"J Neurochem"},{"key":"1350_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10090637","author":"E Dubchenko","year":"2020","unstructured":"Dubchenko E, Ivanov A, Spirina N, Smirnova N, Melnikov M, Boyko A, Gusev E, Kubatiev A (2020) Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci10090637","journal-title":"Brain Sci"},{"issue":"7293","key":"1350_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357\u20131361. https:\/\/doi.org\/10.1038\/nature08938","journal-title":"Nature"},{"issue":"7","key":"1350_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ene.13919","volume":"26","author":"R Durcan","year":"2019","unstructured":"Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ (2019) Prevalence and duration of non-motor symptoms in prodromal Parkinson\u2019s disease. Eur J Neurol 26(7):979\u2013985. https:\/\/doi.org\/10.1111\/ene.13919","journal-title":"Eur J Neurol"},{"issue":"1","key":"1350_CR50","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/andr.12672","volume":"8","author":"ARM Elshahid","year":"2020","unstructured":"Elshahid ARM, Shahein IM, Mohammed YF, Ismail NF, Zakarria H, GamalEl Din SF (2020) Folic acid supplementation improves erectile function in patients with idiopathic vasculogenic erectile dysfunction by lowering peripheral and penile homocysteine plasma levels: a case-control study. Andrology 8(1):148\u2013153. https:\/\/doi.org\/10.1111\/andr.12672","journal-title":"Andrology"},{"key":"1350_CR51","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch4","author":"NS Erekat","year":"2018","unstructured":"Erekat NS (2018) Apoptosis and its role in parkinson\u2019s disease. Exon Pub. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch4","journal-title":"Exon Pub"},{"key":"1350_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040867","author":"R Esse","year":"2019","unstructured":"Esse R, Barroso M, Tavares de Almeida I, Castro R (2019) The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20040867","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1350_CR53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12265-019-09900-6","volume":"12","author":"X Fan","year":"2019","unstructured":"Fan X, Wang E, He J, Zhang L, Zeng X, Gui Y, Sun Q, Song Y, Yuan H (2019) Ligustrazine protects homocysteine-induced apoptosis in human umbilical vein endothelial cells by modulating mitochondrial dysfunction. J Cardiovasc Transl Res 12(6):591\u2013599. https:\/\/doi.org\/10.1007\/s12265-019-09900-6","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"1350_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, Ma JH, Wang XM (2020) Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflammation 17(1):11. https:\/\/doi.org\/10.1186\/s12974-019-1670-6","journal-title":"J Neuroinflammation"},{"issue":"8","key":"1350_CR55","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s10571-017-0478-0","volume":"37","author":"JL Faverzani","year":"2017","unstructured":"Faverzani JL, Hammerschmidt TG, Sitta A, Deon M, Wajner M, Vargas CR (2017) Oxidative stress in homocystinuria due to cystathionine \u00df-synthase deficiency: findings in patients and in animal models. Cell Mol Neurobiol 37(8):1477\u20131485. https:\/\/doi.org\/10.1007\/s10571-017-0478-0","journal-title":"Cell Mol Neurobiol"},{"key":"1350_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1471-2202-9-62","volume":"9","author":"N Ferlazzo","year":"2008","unstructured":"Ferlazzo N, Condello S, Curr\u00f2 M, Parisi G, Ientile R, Caccamo D (2008) NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells. BMC Neurosci 9:62. https:\/\/doi.org\/10.1186\/1471-2202-9-62","journal-title":"BMC Neurosci"},{"key":"1350_CR57","doi-asserted-by":"publisher","first-page":"216298","DOI":"10.4061\/2011\/216298","volume":"2011","author":"PM Flood","year":"2011","unstructured":"Flood PM, Qian L, Peterson LJ, Zhang F, Shi JS, Gao HM, Hong JS (2011) Transcriptional factor NF-\u03baB as a target for therapy in parkinson\u2019s disease. Parkinsons Dis 2011:216298. https:\/\/doi.org\/10.4061\/2011\/216298","journal-title":"Parkinsons Dis"},{"issue":"47","key":"1350_CR58","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A 104(47):18754\u201318759. https:\/\/doi.org\/10.1073\/pnas.0704908104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1350_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bbr.2012.05.011","volume":"233","author":"H Haghdoost-Yazdi","year":"2012","unstructured":"Haghdoost-Yazdi H, Fraidouni N, Faraji A, Jahanihashemi H, Sarookhani M (2012) High intake of folic acid or complex of B vitamins provides anti-parkinsonism effect: no role for serum level of homocysteine. Behav Brain Res 233(2):375\u2013381. https:\/\/doi.org\/10.1016\/j.bbr.2012.05.011","journal-title":"Behav Brain Res"},{"issue":"1","key":"1350_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mds.27874","volume":"35","author":"ME Haque","year":"2020","unstructured":"Haque ME, Akther M, Jakaria M, Kim IS, Azam S, Choi DK (2020) Targeting the microglial NLRP3 inflammasome and its role in Parkinson\u2019s disease. Mov Disord 35(1):20\u201333. https:\/\/doi.org\/10.1002\/mds.27874","journal-title":"Mov Disord"},{"issue":"8","key":"1350_CR61","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s12603-016-0688-z","volume":"20","author":"J Hara","year":"2016","unstructured":"Hara J, Shankle WR, Barrentine LW, Curole MV (2016) Novel therapy of hyperhomocysteinemia in mild cognitive impairment, alzheimer\u2019s disease, and other dementing disorders. J Nutr Health Aging 20(8):825\u2013834. https:\/\/doi.org\/10.1007\/s12603-016-0688-z","journal-title":"J Nutr Health Aging"},{"issue":"6","key":"1350_CR62","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.Wnf.0000236763.16032.60","volume":"29","author":"S Hassin-Baer","year":"2006","unstructured":"Hassin-Baer S, Cohen O, Vakil E, Sela BA, Nitsan Z, Schwartz R, Chapman J, Tanne D (2006) Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Clin Neuropharmacol 29(6):305\u2013311. https:\/\/doi.org\/10.1097\/01.Wnf.0000236763.16032.60","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"1350_CR63","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, N\u00fa\u00f1ez G (2016) Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci 41(12):1012\u20131021. https:\/\/doi.org\/10.1016\/j.tibs.2016.09.002","journal-title":"Trends Biochem Sci"},{"key":"1350_CR64","volume-title":"Focus on Extrapyramidal Dysfunction","author":"I Heider","year":"2004","unstructured":"Heider I, Lehmensiek V, Lenk T, M\u00fcller T, Storch A (2004) Dopaminergic neurotoxicity of Homocysteine and its derivatives in primary mesencephalic cultures. Focus on Extrapyramidal Dysfunction. Springer, Chamber"},{"issue":"1","key":"1350_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10753-018-0873-9","volume":"42","author":"H Hu","year":"2019","unstructured":"Hu H, Wang C, Jin Y, Meng Q, Liu Q, Liu Z, Liu K, Liu X, Sun H (2019) Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4\/NF-\u03baB and GRP78\/PERK pathways in human aorta endothelial cells. Inflammation 42(1):64\u201380. https:\/\/doi.org\/10.1007\/s10753-018-0873-9","journal-title":"Inflammation"},{"issue":"14","key":"1350_CR66","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S Hunot","year":"1997","unstructured":"Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A 94(14):7531\u20137536. https:\/\/doi.org\/10.1073\/pnas.94.14.7531","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1350_CR67","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J Pharmacol Sci 144(3):151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"issue":"15","key":"1350_CR68","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.lfs.2005.02.014","volume":"77","author":"C Isobe","year":"2005","unstructured":"Isobe C, Murata T, Sato C, Terayama Y (2005) Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer\u2019s disease and Parkinson\u2019s disease. Life Sci 77(15):1836\u20131843. https:\/\/doi.org\/10.1016\/j.lfs.2005.02.014","journal-title":"Life Sci"},{"issue":"6","key":"1350_CR69","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jocn.2009.09.034","volume":"17","author":"C Isobe","year":"2010","unstructured":"Isobe C, Abe T, Terayama Y (2010) L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson\u2019s disease. J Clin Neurosci 17(6):717\u2013721. https:\/\/doi.org\/10.1016\/j.jocn.2009.09.034","journal-title":"J Clin Neurosci"},{"key":"1350_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101421","author":"H Javed","year":"2020","unstructured":"Javed H, Meeran MFN, Azimullah S, Bader Eddin L, Dwivedi VD, Jha NK, Ojha S (2020) \u03b1-bisabolol a dietary bioactive phytochemical attenuates dopaminergic neurodegeneration through modulation of oxidative stress neuroinflammation and apoptosis in rotenone-induced rat model of parkinson\u2019s disease. Biomolecules. https:\/\/doi.org\/10.3390\/biom10101421","journal-title":"Biomolecules"},{"issue":"1","key":"1350_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","volume":"135","author":"P Jiang","year":"2018","unstructured":"Jiang P, Dickson DW (2018) Parkinson\u2019s disease: experimental models and reality. Acta Neuropathol 135(1):13\u201332. https:\/\/doi.org\/10.1007\/s00401-017-1788-5","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"1350_CR72","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.parkreldis.2017.07.023","volume":"46","author":"LV Kalia","year":"2018","unstructured":"Kalia LV (2018) Biomarkers for cognitive dysfunction in Parkinson\u2019s disease. Parkinsonism Relat Disord 46(Suppl 1):S19-s23. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"9996","key":"1350_CR73","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. The Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"The Lancet"},{"issue":"4","key":"1350_CR74","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s12035-015-9212-4","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kyles P, Kalani A, Tyagi N (2016) Hydrogen Sulfide ameliorates homocysteine-induced alzheimer\u2019s disease-like pathology, blood-brain barrier disruption, and synaptic disorder. Mol Neurobiol 53(4):2451\u20132467. https:\/\/doi.org\/10.1007\/s12035-015-9212-4","journal-title":"Mol Neurobiol"},{"key":"1350_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207698","author":"P Kaplan","year":"2020","unstructured":"Kaplan P, Tatarkova Z, Sivonova MK, Racay P, Lehotsky J (2020) Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207698","journal-title":"Int J Mol Sci"},{"key":"1350_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081178","author":"K Karolczak","year":"2021","unstructured":"Karolczak K, Watala C (2021) Melatonin as a reducer of neuro- and vasculotoxic oxidative stress induced by homocysteine. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10081178","journal-title":"Antioxidants (Basel)"},{"key":"1350_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113779","author":"I Kawahata","year":"2020","unstructured":"Kawahata I, Fukunaga K (2020) Degradation of tyrosine hydroxylase by the ubiquitin-proteasome system in the pathogenesis of parkinson\u2019s disease and dopa-responsive dystonia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21113779","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1350_CR78","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00702-003-0096-5","volume":"111","author":"BP Kennedy","year":"2004","unstructured":"Kennedy BP, Bottiglieri T, Arning E, Ziegler MG, Hansen LA, Masliah E (2004) Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm 111(4):547\u2013567. https:\/\/doi.org\/10.1007\/s00702-003-0096-5","journal-title":"J Neural Transm"},{"key":"1350_CR79","doi-asserted-by":"publisher","first-page":"373261","DOI":"10.1155\/2012\/373261","volume":"2012","author":"L Kevere","year":"2012","unstructured":"Kevere L, Purvina S, Bauze D, Zeibarts M, Andrezina R, Rizevs A, Jelisejevs S, Piekuse L, Kreile M, Purvins I (2012) Elevated serum levels of Homocysteine as an early prognostic factor of psychiatric disorders in children and adolescents. Schizophr Res Treatment 2012:373261. https:\/\/doi.org\/10.1155\/2012\/373261","journal-title":"Schizophr Res Treatment"},{"issue":"4","key":"1350_CR80","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12272-018-1016-4","volume":"41","author":"J Kim","year":"2018","unstructured":"Kim J, Kim H, Roh H, Kwon Y (2018a) Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res 41(4):372\u2013383. https:\/\/doi.org\/10.1007\/s12272-018-1016-4","journal-title":"Arch Pharm Res"},{"key":"1350_CR81","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jocn.2018.10.079","volume":"58","author":"R Kim","year":"2018","unstructured":"Kim R, Kim HJ, Kim A, Jang M, Kim A, Kim Y, Yoo D, Im JH, Choi JH, Jeon B (2018b) Peripheral blood inflammatory markers in early Parkinson\u2019s disease. J Clin Neurosci 58:30\u201333. https:\/\/doi.org\/10.1016\/j.jocn.2018.10.079","journal-title":"J Clin Neurosci"},{"issue":"4","key":"1350_CR82","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s13167-021-00263-0","volume":"12","author":"L Koklesova","year":"2021","unstructured":"Koklesova L, Mazurakova A, Samec M, Biringer K, Samuel SM, B\u00fcsselberg D, Kubatka P, Golubnitschaja O (2021) Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. Epma j 12(4):477\u2013505. https:\/\/doi.org\/10.1007\/s13167-021-00263-0","journal-title":"Epma j"},{"issue":"1","key":"1350_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000092332","volume":"22","author":"A Komitopoulou","year":"2006","unstructured":"Komitopoulou A, Platokouki H, Kapsimali Z, Pergantou H, Adamtziki E, Aronis S (2006) Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke. Cerebrovasc Dis 22(1):13\u201320","journal-title":"Cerebrovasc Dis"},{"issue":"9","key":"1350_CR84","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s11064-018-2592-x","volume":"43","author":"M Kovalska","year":"2018","unstructured":"Kovalska M, Tothova B, Kovalska L, Tatarkova Z, Kalenska D, Tomascova A, Adamkov M, Lehotsky J (2018) Association of induced hyperhomocysteinemia with alzheimer\u2019s disease-like neurodegeneration in rat cortical neurons after global ischemia-reperfusion injury. Neurochem Res 43(9):1766\u20131778. https:\/\/doi.org\/10.1007\/s11064-018-2592-x","journal-title":"Neurochem Res"},{"key":"1350_CR85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s41470-019-00053-0","volume":"61","author":"M Kovalska","year":"2019","unstructured":"Kovalska M, Tothova B, Kalenska D, Tomascova A, Kovalska L, Adamkov M, Lehotsky J (2019) Association of induced hyperhomocysteinemia with neurodegeneration in rat entorhinal cortex-hippocampal system after global brain ischemia: a progression of Alzheimer\u2019s disease-like pathological features. Act Nerv Super Rediviva 61:31\u201338","journal-title":"Act Nerv Super Rediviva"},{"issue":"3","key":"1350_CR86","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","volume":"60","author":"D Koziorowski","year":"2012","unstructured":"Koziorowski D, Tomasiuk R, Szlufik S, Friedman A (2012) Inflammatory cytokines and NT-proCNP in Parkinson\u2019s disease patients. Cytokine 60(3):762\u2013766. https:\/\/doi.org\/10.1016\/j.cyto.2012.07.030","journal-title":"Cytokine"},{"key":"1350_CR87","first-page":"52","volume":"4","author":"N Kravchuk","year":"2012","unstructured":"Kravchuk N (2012) Hyperhomocysteinemia, cardiovascular disease and type 2 diabetes. Health Ukrainy 4:52\u201356","journal-title":"Health Ukrainy"},{"issue":"18","key":"1350_CR88","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/jneurosci.20-18-06920.2000","volume":"20","author":"II Kruman","year":"2000","unstructured":"Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20(18):6920\u20136926. https:\/\/doi.org\/10.1523\/jneurosci.20-18-06920.2000","journal-title":"J Neurosci"},{"issue":"4","key":"1350_CR89","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1074\/jbc.M207129200","volume":"278","author":"KJ Ladner","year":"2003","unstructured":"Ladner KJ, Caligiuri MA, Guttridge DC (2003) Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278(4):2294\u20132303. https:\/\/doi.org\/10.1074\/jbc.M207129200","journal-title":"J Biol Chem"},{"issue":"5","key":"1350_CR90","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T (2022) Trial of cinpanemab in early parkinson\u2019s disease. N Engl J Med 387(5):408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"},{"issue":"7","key":"1350_CR91","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.autrev.2007.03.008","volume":"6","author":"PE Lazzerini","year":"2007","unstructured":"Lazzerini PE, Capecchi PL, Selvi E, Lorenzini S, Bisogno S, Galeazzi M, Laghi Pasini F (2007) Hyperhomocysteinemia, inflammation and autoimmunity. Autoimmun Rev 6(7):503\u2013509. https:\/\/doi.org\/10.1016\/j.autrev.2007.03.008","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1350_CR92","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuro.2005.01.008","volume":"26","author":"ES Lee","year":"2005","unstructured":"Lee ES, Chen H, Soliman KF, Charlton CG (2005) Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology 26(3):361\u2013371. https:\/\/doi.org\/10.1016\/j.neuro.2005.01.008","journal-title":"Neurotoxicology"},{"issue":"2","key":"1350_CR93","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/biof.5520340201","volume":"34","author":"HC Lin","year":"2008","unstructured":"Lin HC, Yang CM, Liu CL, Hu ML (2008) Synergistic effects of homocysteine, S-adenosylhomocysteine and adenosine on apoptosis in BV-2 murine microglial cells. BioFactors 34(2):81\u201395. https:\/\/doi.org\/10.1002\/biof.5520340201","journal-title":"BioFactors"},{"issue":"5","key":"1350_CR94","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/mib.0000000000000735","volume":"22","author":"JC Lin","year":"2016","unstructured":"Lin JC, Lin CS, Hsu CW, Lin CL, Kao CH (2016) Association between parkinson\u2019s disease and inflammatory bowel disease: a nationwide taiwanese retrospective cohort study. Inflamm Bowel Dis 22(5):1049\u20131055. https:\/\/doi.org\/10.1097\/mib.0000000000000735","journal-title":"Inflamm Bowel Dis"},{"key":"1350_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11060354","author":"RI Litvinov","year":"2021","unstructured":"Litvinov RI, Peshkova AD, Le Minh G, Khaertdinov NN, Evtugina NG, Sitdikova GF, Weisel JW (2021) Effects of hyperhomocysteinemia on the platelet-driven contraction of blood clots. Metabolites. https:\/\/doi.org\/10.3390\/metabo11060354","journal-title":"Metabolites"},{"key":"1350_CR96","doi-asserted-by":"publisher","unstructured":"Liu M, Yin Y-J, Zheng M-q, Shi X-C, Liu D, Liu D-Y, Liu G, Wei M (2022) Arterial injury mechanism of Homocysteine in patients with premature coronary heart disease after PCI. https:\/\/doi.org\/10.21203\/rs.3.rs-1287891\/v1","DOI":"10.21203\/rs.3.rs-1287891\/v1"},{"issue":"2","key":"1350_CR97","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2741\/4131","volume":"18","author":"S Meng","year":"2013","unstructured":"Meng S, Ciment S, Jan M, Tran T, Pham H, Cueto R, Yang XF, Wang H (2013) Homocysteine induces inflammatory transcriptional signaling in monocytes. Front Biosci (landmark Ed) 18(2):685\u2013695. https:\/\/doi.org\/10.2741\/4131","journal-title":"Front Biosci (landmark Ed)"},{"issue":"1","key":"1350_CR98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11064-008-9656-2","volume":"34","author":"RL Miller","year":"2009","unstructured":"Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson\u2019s disease. Neurochem Res 34(1):55\u201365. https:\/\/doi.org\/10.1007\/s11064-008-9656-2","journal-title":"Neurochem Res"},{"key":"1350_CR99","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201811806250","author":"YS Mironova","year":"2018","unstructured":"Mironova YS, Zhukova IA, Zhukova NG, Alifirova VM, Izhboldina OP, Latypova AV (2018) Parkinson\u2019s disease and glutamate excitotoxicity. Zh Nevrol Psikhiatr Im S S Korsakova. https:\/\/doi.org\/10.17116\/jnevro201811806250","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"3","key":"1350_CR100","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.15190\/d.2021.14","volume":"9","author":"RR Mititelu","year":"2021","unstructured":"Mititelu RR, Albu CV, Bacanoiu MV, Padureanu V, Padureanu R, Olaru G, Buga AM, Balasoiu M (2021) Homocysteine as a Predictor Tool in Multiple Sclerosis. Discoveries (Craiova) 9(3):e135. https:\/\/doi.org\/10.15190\/d.2021.14","journal-title":"Discoveries (Craiova)"},{"key":"1350_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fncir.2019.00011","volume":"13","author":"VR Muddapu","year":"2019","unstructured":"Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S (2019) A computational model of loss of dopaminergic cells in parkinson\u2019s disease due to glutamate-induced excitotoxicity. Front Neural Circuits 13:11. https:\/\/doi.org\/10.3389\/fncir.2019.00011","journal-title":"Front Neural Circuits"},{"issue":"9","key":"1350_CR102","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/mds.22607","volume":"24","author":"T M\u00fcller","year":"2009","unstructured":"M\u00fcller T, Kuhn W (2009) Homocysteine levels after acute levodopa intake in patients with Parkinson\u2019s disease. Mov Disord 24(9):1339\u20131343. https:\/\/doi.org\/10.1002\/mds.22607","journal-title":"Mov Disord"},{"issue":"1","key":"1350_CR103","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/s0304-3940(01)01972-3","volume":"308","author":"T M\u00fcller","year":"2001","unstructured":"M\u00fcller T, Woitalla D, Hauptmann B, Fowler B, Kuhn W (2001) Decrease of methionine and S-adenosylmethionine and increase of Homocysteine in treated patients with Parkinson\u2019s disease. Neurosci Lett 308(1):54\u201356. https:\/\/doi.org\/10.1016\/s0304-3940(01)01972-3","journal-title":"Neurosci Lett"},{"key":"1350_CR104","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphar.2019.01294","volume":"10","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena A, Andikoetxea A, G\u00f3mez-Esteban JC, Gabilondo I (2019) Contribution of the GABAergic system to non-motor manifestations in premotor and early stages of parkinson\u2019s disease. Front Pharmacol 10:1294. https:\/\/doi.org\/10.3389\/fphar.2019.01294","journal-title":"Front Pharmacol"},{"issue":"6","key":"1350_CR105","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/bja\/aen085","volume":"100","author":"PS Myles","year":"2008","unstructured":"Myles PS, Chan MT, Leslie K, Peyton P, Paech M, Forbes A (2008) Effect of nitrous oxide on plasma homocysteine and folate in patients undergoing major surgery. Br J Anaesth 100(6):780\u2013786. https:\/\/doi.org\/10.1093\/bja\/aen085","journal-title":"Br J Anaesth"},{"issue":"4","key":"1350_CR106","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00702-018-1903-3","volume":"126","author":"T Nagatsu","year":"2019","unstructured":"Nagatsu T, Nakashima A, Ichinose H, Kobayashi K (2019) Human tyrosine hydroxylase in Parkinson\u2019s disease and in related disorders. J Neural Transm (vienna) 126(4):397\u2013409. https:\/\/doi.org\/10.1007\/s00702-018-1903-3","journal-title":"J Neural Transm (vienna)"},{"issue":"6","key":"1350_CR107","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1530\/eje.1.02303","volume":"155","author":"HR Nakhai Pour","year":"2006","unstructured":"Nakhai Pour HR, Grobbee DE, Muller M, Emmelot-Vonk M, van der Schouw YT (2006) Serum sex hormone and plasma homocysteine levels in middle-aged and elderly men. Eur J Endocrinol 155(6):887\u2013893. https:\/\/doi.org\/10.1530\/eje.1.02303","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1350_CR108","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.arcmed.2014.03.001","volume":"45","author":"K Nazef","year":"2014","unstructured":"Nazef K, Khelil M, Chelouti H, Kacimi G, Bendini M, Tazir M, Belarbi S, El Hadi CM, Djerdjouri B (2014) Hyperhomocysteinemia is a risk factor for Alzheimer\u2019s disease in an Algerian population. Arch Med Res 45(3):247\u2013250. https:\/\/doi.org\/10.1016\/j.arcmed.2014.03.001","journal-title":"Arch Med Res"},{"issue":"3","key":"1350_CR109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.thromres.2004.12.005","volume":"116","author":"TK Nilsson","year":"2005","unstructured":"Nilsson TK, Boman K, Jansson JH, Th\u00f8gersen AM, Berggren M, Broberg A, Granlund A (2005) Comparison of soluble thrombomodulin, von Willebrand factor, tPA\/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8\u201311 years. Thromb Res 116(3):249\u2013254. https:\/\/doi.org\/10.1016\/j.thromres.2004.12.005","journal-title":"Thromb Res"},{"issue":"6","key":"1350_CR110","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/wnp.0000000000000604","volume":"36","author":"L Norcliffe-Kaufmann","year":"2019","unstructured":"Norcliffe-Kaufmann L (2019) The vagus and glossopharyngeal nerves in two autonomic disorders. J Clin Neurophysiol 36(6):443\u2013451. https:\/\/doi.org\/10.1097\/wnp.0000000000000604","journal-title":"J Clin Neurophysiol"},{"issue":"12","key":"1350_CR111","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/mds.20253","volume":"19","author":"PE O\u2019Suilleabhain","year":"2004","unstructured":"O\u2019Suilleabhain PE, Bottiglieri T, Dewey RB Jr, Sharma S, Diaz-Arrastia R (2004) Modest increase in plasma homocysteine follows levodopa initiation in Parkinson\u2019s disease. Mov Disord 19(12):1403\u20131408. https:\/\/doi.org\/10.1002\/mds.20253","journal-title":"Mov Disord"},{"issue":"10","key":"1350_CR112","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1373\/clinchem.2009.125021","volume":"55","author":"R Obeid","year":"2009","unstructured":"Obeid R, Schadt A, Dillmann U, Kostopoulos P, Fassbender K, Herrmann W (2009) Methylation status and neurodegenerative markers in Parkinson disease. Clin Chem 55(10):1852\u20131860. https:\/\/doi.org\/10.1373\/clinchem.2009.125021","journal-title":"Clin Chem"},{"issue":"5","key":"1350_CR113","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim JK, Silwal P, Sasakawa C, Jo EK (2021) An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol 18(5):1141\u20131160. https:\/\/doi.org\/10.1038\/s41423-021-00670-3","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"1350_CR114","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1038\/cddis.2014.258","volume":"5","author":"R Park","year":"2014","unstructured":"Park R, Kook SY, Park JC, Mook-Jung I (2014) A\u03b21\u201342 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-\u03baB signaling. Cell Death Dis 5(6):e1299. https:\/\/doi.org\/10.1038\/cddis.2014.258","journal-title":"Cell Death Dis"},{"issue":"1","key":"1350_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10072-004-0219-5","volume":"25","author":"L Parnetti","year":"2004","unstructured":"Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T (2004) Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci 25(1):13\u201317. https:\/\/doi.org\/10.1007\/s10072-004-0219-5","journal-title":"Neurol Sci"},{"key":"1350_CR116","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fnagi.2018.00350","volume":"10","author":"BR Price","year":"2018","unstructured":"Price BR, Wilcock DM, Weekman EM (2018) Hyperhomocysteinemia as a risk factor for vascular contributions to cognitive impairment and dementia. Front Aging Neurosci 10:350. https:\/\/doi.org\/10.3389\/fnagi.2018.00350","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1350_CR117","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12974-018-1236-z","volume":"15","author":"C Qiao","year":"2018","unstructured":"Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, Ding J, Lu M, Hu G (2018) Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson\u2019s disease. J Neuroinflammation 15(1):193. https:\/\/doi.org\/10.1186\/s12974-018-1236-z","journal-title":"J Neuroinflammation"},{"key":"1350_CR118","first-page":"1","volume":"2020","author":"SN Rai","year":"2020","unstructured":"Rai SN, Chaturvedi VK, Singh P, Singh BK, Singh MP (2020) Mucuna pruriens in Parkinson\u2019s and in some other diseases: recent advancement and future prospective. Biotech. 2020:1\u20131","journal-title":"Biotech."},{"issue":"9","key":"1350_CR119","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4103\/1673-5374.306066","volume":"16","author":"SN Rai","year":"2021","unstructured":"Rai SN, Singh P, Varshney R, Chaturvedi VK, Vamanu E, Singh MP, Singh BK (2021) Promising drug targets and associated therapeutic interventions in Parkinson\u2019s disease. Neural Regen Res 16(9):1730","journal-title":"Neural Regen Res"},{"issue":"2","key":"1350_CR120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/jnnp.2005.072199","volume":"77","author":"GS Ramsaransing","year":"2006","unstructured":"Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J (2006) Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 77(2):189\u2013192. https:\/\/doi.org\/10.1136\/jnnp.2005.072199","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1350_CR121","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1002\/fsn3.1818","volume":"8","author":"T Rehman","year":"2020","unstructured":"Rehman T, Shabbir MA, Inam-Ur-Raheem M, Manzoor MF, Ahmad N, Liu ZW, Ahmad MH, Siddeeg A, Abid M, Aadil RM (2020) Cysteine and Homocysteine as biomarker of various diseases. Food Sci Nutr 8(9):4696\u20134707. https:\/\/doi.org\/10.1002\/fsn3.1818","journal-title":"Food Sci Nutr"},{"issue":"5","key":"1350_CR122","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1161\/circulationaha.122.059410","volume":"146","author":"PM Ridker","year":"2022","unstructured":"Ridker PM, Rifai N, MacFadyen J, Glynn RJ, Jiao L, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Mason RP, Bhatt DL (2022) Effects of randomized treatment with icosapent ethyl and a mineral oil comparator on interleukin-1\u03b2, interleukin-6, c-reactive protein, oxidized low-density lipoprotein cholesterol, homocysteine, lipoprotein(a), and lipoprotein-associated phospholipase a2: a reduce-it biomarker substudy. Circulation 146(5):372\u2013379. https:\/\/doi.org\/10.1161\/circulationaha.122.059410","journal-title":"Circulation"},{"issue":"434","key":"1350_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120148","volume":"15","author":"F Sampedro","year":"2022","unstructured":"Sampedro F, Mart\u00ednez-Horta S, Horta-Barba A, Grothe MJ, Labrador-Espinosa MA, Jes\u00fas S, Adarmes-G\u00f3mez A, Carrillo F, Puig-Davi A, Lora FR, Barber\u00e1 MA (2022) Increased homocysteine levels correlate with cortical structural damage in Parkinson\u2019s disease. J Neurol Sci 15(434):120148","journal-title":"J Neurol Sci"},{"issue":"1","key":"1350_CR124","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/1389201043489657","volume":"5","author":"K Schroecksnadel","year":"2004","unstructured":"Schroecksnadel K, Frick B, Wirleitner B, Winkler C, Schennach H, Fuchs D (2004) Moderate hyperhomocysteinemia and immune activation. Curr Pharm Biotechnol 5(1):107\u2013118. https:\/\/doi.org\/10.2174\/1389201043489657","journal-title":"Curr Pharm Biotechnol"},{"issue":"4","key":"1350_CR125","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3349\/ymj.2010.51.4.526","volume":"51","author":"H Seo","year":"2010","unstructured":"Seo H, Oh H, Park H, Park M, Jang Y, Lee M (2010) Contribution of dietary intakes of antioxidants to homocysteine-induced low density lipoprotein (LDL) oxidation in atherosclerotic patients. Yonsei Med J 51(4):526\u2013533. https:\/\/doi.org\/10.3349\/ymj.2010.51.4.526","journal-title":"Yonsei Med J"},{"issue":"7","key":"1350_CR126","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D\u2019Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med 346(7):476\u2013483. https:\/\/doi.org\/10.1056\/NEJMoa011613","journal-title":"N Engl J Med"},{"issue":"3","key":"1350_CR127","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ana.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570\u2013580. https:\/\/doi.org\/10.1002\/ana.22311","journal-title":"Ann Neurol"},{"issue":"8","key":"1350_CR128","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/prot.25681","volume":"87","author":"Y Silla","year":"2019","unstructured":"Silla Y, Varshney S, Ray A, Basak T, Zinellu A, Sabareesh V, Carru C, Sengupta S (2019) Hydrolysis of homocysteine thiolactone results in the formation of Protein-Cys-S-S-homocysteinylation. Proteins 87(8):625\u2013634. https:\/\/doi.org\/10.1002\/prot.25681","journal-title":"Proteins"},{"issue":"3","key":"1350_CR129","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12640-019-00147-2","volume":"37","author":"SS Singh","year":"2020","unstructured":"Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Singh SP (2020) NF-\u03baB-mediated neuroinflammation in parkinson\u2019s disease and potential therapeutic effect of polyphenols. Neurotox Res 37(3):491\u2013507. https:\/\/doi.org\/10.1007\/s12640-019-00147-2","journal-title":"Neurotox Res"},{"issue":"4","key":"1350_CR130","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/joim.13279","volume":"290","author":"AD Smith","year":"2021","unstructured":"Smith AD, Refsum H (2021) Homocysteine - from disease biomarker to disease prevention. J Intern Med 290(4):826\u2013854. https:\/\/doi.org\/10.1111\/joim.13279","journal-title":"J Intern Med"},{"issue":"7","key":"1350_CR131","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1007\/s11064-015-1598-x","volume":"40","author":"S Srivastav","year":"2015","unstructured":"Srivastav S, Singh SK, Yadav AK, Srikrishna S (2015) Folic acid supplementation ameliorates oxidative stress, metabolic functions and developmental anomalies in a novel fly model of parkinson\u2019s disease. Neurochem Res 40(7):1350\u20131359. https:\/\/doi.org\/10.1007\/s11064-015-1598-x","journal-title":"Neurochem Res"},{"issue":"6","key":"1350_CR132","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J (2020) Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol 16(6):303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"issue":"12","key":"1350_CR133","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1136\/jnnp.2008.151555","volume":"79","author":"CE Teunissen","year":"2008","unstructured":"Teunissen CE, Killestein J, Kragt JJ, Polman CH, Dijkstra CD, Blom HJ (2008) Serum homocysteine levels in relation to clinical progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 79(12):1349\u20131353. https:\/\/doi.org\/10.1136\/jnnp.2008.151555","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1350_CR134","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1515\/cclm.2007.342","volume":"45","author":"N Tyagi","year":"2007","unstructured":"Tyagi N, Lominadze D, Gillespie W, Moshal KS, Sen U, Rosenberger DS, Steed M, Tyagi SC (2007) Differential expression of gamma-aminobutyric acid receptor A (GABA(A)) and effects of Homocysteine. Clin Chem Lab Med 45(12):1777\u20131784. https:\/\/doi.org\/10.1515\/cclm.2007.342","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"1350_CR135","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hbm.24857","volume":"41","author":"AJM van Nuland","year":"2020","unstructured":"van Nuland AJM, den Ouden HEM, Zach H, Dirkx MFM, van Asten JJA, Scheenen TWJ, Toni I, Cools R, Helmich RC (2020) GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease. Hum Brain Mapp 41(4):1017\u20131029. https:\/\/doi.org\/10.1002\/hbm.24857","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"1350_CR136","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1567205011310020007","volume":"10","author":"L Veryard","year":"2013","unstructured":"Veryard L, Jones E, Weaving G, Smith E, Cheek L, Wickramasinghe A, Tabet N (2013) Pro-inflammatory cytokines IL-1\u03b2 and TNF-\u03b1 are not associated with plasma homocysteine concentration in Alzheimer\u2019s disease. Curr Alzheimer Res 10(2):174\u2013179","journal-title":"Curr Alzheimer Res"},{"issue":"8","key":"1350_CR137","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/labinvest.2017.30","volume":"97","author":"R Wang","year":"2017","unstructured":"Wang R, Wang Y, Mu N, Lou X, Li W, Chen Y, Fan D, Tan H (2017) Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Lab Invest 97(8):922\u2013934. https:\/\/doi.org\/10.1038\/labinvest.2017.30","journal-title":"Lab Invest"},{"key":"1350_CR138","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-018-0114-x","volume":"4","author":"XJ Wang","year":"2018","unstructured":"Wang XJ, Chen W, Fu XT, Ma JK, Wang MH, Hou YJ, Tian DC, Fu XY, Fan CD (2018) Reversal of homocysteine-induced neurotoxicity in rat hippocampal neurons by astaxanthin: evidences for mitochondrial dysfunction and signaling crosstalk. Cell Death Discov 4:50. https:\/\/doi.org\/10.1038\/s41420-018-0114-x","journal-title":"Cell Death Discov"},{"key":"1350_CR139","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","volume":"67","author":"S Wang","year":"2019","unstructured":"Wang S, Yuan YH, Chen NH, Wang HB (2019) The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease. Int Immunopharmacol 67:458\u2013464. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.019","journal-title":"Int Immunopharmacol"},{"key":"1350_CR140","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","volume":"11","author":"Z Wei","year":"2018","unstructured":"Wei Z, Li X, Li X, Liu Q, Cheng Y (2018) Oxidative stress in parkinson\u2019s disease: a systematic review and meta-analysis. Front Mol Neurosci 11:236. https:\/\/doi.org\/10.3389\/fnmol.2018.00236","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"1350_CR141","doi-asserted-by":"publisher","first-page":"E1002","DOI":"10.1152\/ajpendo.00518.2004","volume":"288","author":"CW Woo","year":"2005","unstructured":"Woo CW, Siow YL, Pierce GN, Choy PC, Minuk GY, Mymin DOK (2005) Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 288(5):E1002-1010. https:\/\/doi.org\/10.1152\/ajpendo.00518.2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1350_CR142","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.redox.2018.09.021","volume":"20","author":"X Wu","year":"2019","unstructured":"Wu X, Zhang L, Miao Y, Yang J, Wang X, Wang CC, Feng J, Wang L (2019) Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis. Redox Biol 20:46\u201359. https:\/\/doi.org\/10.1016\/j.redox.2018.09.021","journal-title":"Redox Biol"},{"issue":"1","key":"1350_CR143","doi-asserted-by":"publisher","first-page":"17401","DOI":"10.1038\/s41598-020-74596-7","volume":"10","author":"R Xu","year":"2020","unstructured":"Xu R, Huang F, Wang Y, Liu Q, Lv Y, Zhang Q (2020) Gender- and age-related differences in homocysteine concentration: a cross-sectional study of the general population of China. Sci Rep 10(1):17401. https:\/\/doi.org\/10.1038\/s41598-020-74596-7","journal-title":"Sci Rep"},{"key":"1350_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/biom10070995","author":"O Yakovleva","year":"2020","unstructured":"Yakovleva O, Bogatova K, Mukhtarova R, Yakovlev A, Shakhmatova V, Gerasimova E, Ziyatdinova G, Hermann A, Sitdikova G (2020) Hydrogen sulfide alleviates anxiety, motor, and cognitive dysfunctions in rats with maternal hyperhomocysteinemia via mitigation of oxidative stress. Biomolecules. https:\/\/doi.org\/10.3390\/biom10070995","journal-title":"Biomolecules"},{"issue":"2","key":"1350_CR145","first-page":"103","volume":"57","author":"F Yang","year":"2005","unstructured":"Yang F, Tan H-M, Wang H (2005) Hyperhomocysteinemia and atherosclerosis. Acta Physiologica Sinica-Chinese edition- 57(2):103","journal-title":"Acta Physiologica Sinica-Chinese edition-"},{"key":"1350_CR146","doi-asserted-by":"publisher","first-page":"105651","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, Zheng J, Li W, Le B, Chen Y, Pan H, Huang S, Wang S, Wang Q (2019) Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int Immunopharmacol 75:105651. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.036","journal-title":"Int Immunopharmacol"},{"key":"1350_CR147","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, Ray Dorsey E, Dahodwala N, Cintina I, Hogan P, Thompson T (2020) Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Parkinsons Dis 6:15. https:\/\/doi.org\/10.1038\/s41531-020-0117-1","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"1350_CR148","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/mds.26005","volume":"29","author":"JH Yoon","year":"2014","unstructured":"Yoon JH, Lee JS, Yong SW, Hong JM, Lee PH (2014) Endothelial dysfunction and hyperhomocysteinemia in Parkinson\u2019s disease: flow-mediated dilation study. Mov Disord 29(12):1551\u20131555. https:\/\/doi.org\/10.1002\/mds.26005","journal-title":"Mov Disord"},{"issue":"10","key":"1350_CR149","doi-asserted-by":"publisher","first-page":"18602","DOI":"10.1002\/jcp.28498","volume":"234","author":"Y Zhai","year":"2019","unstructured":"Zhai Y, Behera J, Tyagi SC, Tyagi N (2019) Hydrogen sulfide attenuates homocysteine-induced osteoblast dysfunction by inhibiting mitochondrial toxicity. J Cell Physiol 234(10):18602\u201318614. https:\/\/doi.org\/10.1002\/jcp.28498","journal-title":"J Cell Physiol"},{"issue":"6","key":"1350_CR150","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1002\/jcb.28217","volume":"120","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang L, Zhou X, Geng J, Li X (2019) The immunomodulatory mechanism of brain injury induced by hyperhomocysteinemia in spontaneously hypertensive rats. J Cell Biochem 120(6):9421\u20139429. https:\/\/doi.org\/10.1002\/jcb.28217","journal-title":"J Cell Biochem"},{"key":"1350_CR151","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.freeradbiomed.2020.08.029","volume":"160","author":"X Zhang","year":"2020","unstructured":"Zhang X, Huang Z, Xie Z, Chen Y, Zheng Z, Wei X, Huang B, Shan Z, Liu J, Fan S, Chen J, Zhao F (2020) Homocysteine induces oxidative stress and ferroptosis of nucleus pulposus via enhancing methylation of GPX4. Free Radic Biol Med 160:552\u2013565. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.08.029","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"1350_CR152","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3892\/etm.2021.9914","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Wang L, Li X, Geng J (2021) Preliminary analysis of immunoregulatory mechanism of hyperhomocysteinemia-induced brain injury in Wistar-Kyoto rats. Exp Ther Med 21(5):483. https:\/\/doi.org\/10.3892\/etm.2021.9914","journal-title":"Exp Ther Med"},{"issue":"10","key":"1350_CR153","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.4103\/1673-5374.308102","volume":"16","author":"J Zhao","year":"2021","unstructured":"Zhao J, Kumar M, Sharma J, Yuan Z (2021) Arbutin effectively ameliorates the symptoms of Parkinson\u2019s disease: the role of adenosine receptors and cyclic adenosine monophosphate. Neural Regen Res 16(10):2030","journal-title":"Neural Regen Res"},{"key":"1350_CR154","doi-asserted-by":"publisher","first-page":"4797861","DOI":"10.1155\/2022\/4797861","volume":"2022","author":"M Zhong","year":"2022","unstructured":"Zhong M, Zhu S, Gu R, Wang Y, Jiang Y, Bai Y, Jiang X, Shen B, Yan J, Pan Y, Zhu J, Zhang L (2022) Elevation of plasma homocysteine and minor hallucinations in parkinson\u2019s disease: a cross-sectional study. Behav Neurol 2022:4797861. https:\/\/doi.org\/10.1155\/2022\/4797861","journal-title":"Behav Neurol"},{"issue":"9","key":"1350_CR155","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tips.2011.05.003","volume":"32","author":"JM Zhuo","year":"2011","unstructured":"Zhuo JM, Wang H, Pratic\u00f2 D (2011) Is hyperhomocysteinemia an Alzheimer\u2019s disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32(9):562\u2013571. https:\/\/doi.org\/10.1016\/j.tips.2011.05.003","journal-title":"Trends Pharmacol Sci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-023-01350-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T18:56:27Z","timestamp":1702234587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-023-01350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":155,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s10571-023-01350-8","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"7 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}